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Abstract
Background: The overgrowth-associated Beckwith-Wiedemann syndrome (BWS) and the undergrowth-associated
Silver-Russell syndrome (SRS) are characterized by heterogeneous molecular defects affecting a large imprinted
gene cluster at chromosome 11p15.5-p15.4. While maternal and paternal duplications of the entire cluster
consistently result in SRS and BWS, respectively, the phenotypes associated with smaller duplications are difficult to
predict due to the complexity of imprinting regulation. Here, we describe two cases with novel inherited partial
duplications of the centromeric domain on chromosome 11p15 associated with contrasting growth phenotypes.
Findings: In a male patient affected by intrauterine growth restriction and postnatal short stature, we identified an
in cis maternally inherited duplication of 0.88 Mb including the CDKN1C gene that was significantly up-regulated.
The duplication did not include the long non-coding RNA KCNQ1OT1 nor the imprinting control region of the
centromeric domain (KCNQ1OT1:TSS-DMR or ICR2) in which methylation was normal. In the mother, also referring a
growth restriction phenotype in her infancy, the duplication was de novo and present on her paternal chromosome.
A different in cis maternal duplication, 1.13 Mb long and including the abovementioned duplication, was observed in a
child affected by Tetralogy of Fallot but with normal growth. In this case, the rearrangement also included most of the
KCNQ1OT1 gene and resulted in ICR2 loss of methylation (LOM). In this second family, the mother carried the duplication
on her paternal chromosome and showed a normal growth phenotype as well.
Conclusions: We report two novel in cis microduplications encompassing part of the centromeric domain of the 11p15.
5-p15.4 imprinted gene cluster and both including the growth inhibitor CDKN1C gene. Likely, as a consequence of the
differential involvement of the regulatory KCNQ1OT1 RNA and ICR2, the smaller duplication is associated with growth
restriction on both maternal and paternal transmissions, while the larger duplication, although it includes the smaller one,
does not result in any growth anomaly.
Our study provides further insights into the phenotypes associated with imprinted gene alterations and highlights the
importance of carefully evaluating the affected genes and regulatory elements for accurate genetic counselling of the
11p15 chromosomal rearrangements.
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Less than 1 % of human genes are imprinted, that is,
their expression is monoallelic and parent of origin-
dependent as a result of epigenetic modifications
acquired during gametogenesis [1]. Alterations of
imprinted gene expression result in imprinting disorders
(IDs) that are characterized by growth, metabolic, and
developmental anomalies. Imprinted genes are generally
organized in clusters that share regulatory cis-acting
elements, such as enhancers and imprinting control re-
gions (ICRs). The ICRs are 2–4-kb long genomic se-
quences characterized by repressive and permissive
epigenetic marks on the opposite parental alleles. A large
cluster of imprinted genes that is located on chromo-
some 11p15.5-p15.4 harbors two independent ICRs,
H19/IGF2:IG (Intergenic)-DMR (also known as ICR1),
and KCNQ1OT1:TSS (transcription start site)-DMR
(also known as ICR2). ICR2 controls the imprinting of
the centromeric domain. This region corresponds to the
promoter of KCNQ1OT1, a long non-coding RNA that
is transcribed antisense to KCNQ1 and represses in cis
the flanking imprinted genes on the paternal chromo-
some. These include KCNQ1, a member of the potas-
sium channel KQT-family, and two genes with growth
inhibitory properties, CDKN1C and PHLDA2 [1–3].
Opposite genetic and epigenetic anomalies of the
11p15.5-p15.4 region result in the overgrowth-associated
Beckwith-Wiedemann syndrome (BWS, MIM #130650)
[4] and the undergrowth-associated Silver-Russell syn-
drome (SRS, MIM #180860) [5]. The BWS patients
usually show one of the following defects: (1) gain of
methylation (GOM) of ICR1 (5–10 % of the cases); (2)
loss of methylation (LOM) of ICR2 (50 % of the cases);
and (3) aberrant methylation of both ICRs due to seg-
mental paternal uniparental disomy (UPD, 20 % of the
cases) of chromosome 11. Conversely, the SRS patients
frequently show ICR1 LOM (50 % of the cases);
maternal UPD of chromosome 11p15 has been reported
in only one case [1, 6]. CDKN1C variations affecting
CDKN1C function can also cause these diseases. Mater-
nally inherited loss-of-function mutations have been de-
scribed in 5 % of the BWS patients (and 50 % of the
familial cases) while gain-of-function mutations have
been reported in the intrauterine growth restriction
(IUGR)-associated IMAGe syndrome and in a single fa-
milial case of SRS [7, 8].
Deletions/duplications of chromosome 11p15.5-p15.4
have generally been reported in only 2–6 % of BWS and
SRS patients [9], but a more recent study demonstrates
an 8.4 % frequency in BWS patients [10]. Duplications
encompassing the entire imprinted gene cluster are
usually associated with BWS if paternally inherited and
with SRS if maternally inherited. In addition, paternal
duplication of the telomeric domain usually results in
BWS [11, 12] and maternal duplication of the centro-
meric domain results in SRS [13, 14]. The contrasting
phenotypes observed on maternal and paternal transmis-
sion of these chromosome alterations are likely caused
by opposite deregulation of IGF2 in the telomeric do-
main and CDKN1C and PHLDA2 in the centromeric
domain [15]. In the case of smaller duplications encom-
passing only a part of a single domain, the clinical out-
come is difficult to predict because of the complex
regulation of the 11p15 imprinted gene cluster.
Here, we describe two novel submicroscopic in cis du-
plications including part of the centromeric domain of
the 11p15 imprinted gene cluster. The duplications ex-
tend 0.88 and 1.13 Mb from the middle of the KCNQ1
gene toward the centromere, respectively. Despite both
chromosome aberrations involve the CDKN1C gene and
two out of the three putative enhancers [16], we find
that only the smaller one is associated with growth re-
striction. The finding that the larger duplication also in-
cludes a hypomethylated ICR2 and part of KCNQ1OT1
provides a possible explanation for the associated con-
trasting growth phenotypes.
Results
Two unrelated children with rare submicroscopic imbal-
ances in the centromeric domain of the 11p15 imprinted
gene cluster were identified and subjected to further
laboratory analyses and clinical examination. In the
proband of the first family (family 1), a duplication of
about 0.88 Mb of chromosome 11p15.5-p15.4 was iden-
tified by comparative genomic hybridization (CGH) and
single nucleotide polymorphism (SNP) array analyses.
These methods allowed locating the telomeric break-
point between chr11:2,739,336 and chr11:2,742,159 bp
(GRCh37/hg19) within the intron 10 of KCNQ1, about
20-kb centromeric to ICR2, and the centromeric break-
point between chr11:3,632,246 and chr11:3,632,370 bp in
an intergenic region among the pseudogenes LOC650368
and TRPC2 (Fig. 1 and Additional file 1: Figure S1). In the
proband of the second family (family 2), a duplication of
1.13 Mb was identified and its breakpoints defined by
SNP array (Fig. 1). The telomeric breakpoint was
identified inside intron 9 of KCNQ1 gene, about 65 kb
telomeric from the transcription start site of KCNQ1OT1,
while the centromeric breakpoint was identified in intron
10 of the NUP98 gene (arr[GRC37/hg19] dup(11)(p15.5-
p15.4) (2,656,310x 2; 2,656,311-3,782,347x3; 3,782,492x2)).
Family 1
The proband of family 1 was the third son of three
children from unrelated parents. Pes equinovarus was
observed by ultrasound scan by gestational age 16 +
2 weeks and an amniocentesis was obtained. The
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maternally inherited 11p15 duplication was identified.
Due to this finding several ultrasound scans were per-
formed during the pregnancy and IUGR was observed: −
18 % at 30 + 6 weeks of gestation, −25 % at 32 +
5 weeks, −27 % at 34 + 5 weeks, and −30 % at 36 +
5 weeks. Due to IUGR induction of delivery was per-
formed. He was born small for gestational age (SGA)
at gestational age (GA) 37 + 6 weeks. His birth weight
was 2070 g, (−3 SDS), birth length 44 cm (−3 SDS),
and occipital frontal circumference (OFC) 30 cm
(−2.5 SDS). The placenta weight (300 g, <third cen-
tile) was also reduced. Further, blood glucose was
1.4 mmol/l by delivery. He received treatment with
intravenous glucose for 1 day. Afterwards he was only
breast feed. The pes equinovarus was treated with
plaster and tenotomy of the Achilles tendons at
45 days of age.
Physical examination at 14 months confirmed the
growth restriction, in particular the short stature: weight
9.0 kg (−1.5 SDS), length 73 cm (−2.5 SDS), and OFC
45 cm (−1.5 SDS). The father, aged 40 years, was re-
ferred to be of normal stature (176 cm). The mother’s
height was 163 cm and her weight is 59 kg at 38 years of
age. It was referred that in childhood, she was very small
and the general practitioner suspected she was a kind of
a dwarf at 5–6 years of age.
The first son was born by GA 42 weeks with a birth
weight of 3320 g (−0.5 SDS) and a birth length of 52 cm
(average). By 14 years of age, his height was 168 cm (+1
SDS); the second son was born at 33 weeks of gestation.
The spontaneous preterm delivery was caused by mem-
brane rupture. His birth weight was 1575 g (−1.1 SDS),
the birth length 41 cm (−1 SDS). Information on fetal
growth parameters during pregnancy was not available.
He was treated with intravenous glucose infusions age
1–3 days due to low blood glucose (blood glucoses at
day 1: 1.9–2.6 mmol/l). By 7 years, his height was
127 cm (+1 SDS). He was affected by mild attention def-
icit hyperactivity disorder (ADHD).
The presence of the duplication was searched in the
proband relatives by SNP array performed on DNA de-
rived from buccal swab of the brothers and from blood
of the parents and the maternal grandfather. The
chromosome 11 duplication was identified in the mother
and in her second son but not in the first son neither in
the maternal grandfather (Additional file 2: Figure S2).
By studying the segregation of the 11p15 haplotype by
microsatellite analysis we demonstrated that in the
mother the duplication was present on her paternal
chromosome (Fig. 2a and Additional file 3: Figure S3).
This suggests that the duplication originated very early
in development, either in the gametes of the maternal
grandfather or in the somatic cells of the mother.
To confirm the duplication and determine if it was
present in cis or in trans, cells of the umbilical cord of
the proband were analyzed by fluorescence in situ
hybridization (FISH). A bacterial artificial chromosome
(BAC) probe (RP11-11A9, chr11: 3236552-3356012,
green signal in Additional file 4: Figure S4) hybridizing
within the duplicated region and a BAC probe (RP11-
Fig. 1 Extension of the 11p15.5-p15.4 duplications. Copy number analysis at chromosome 11p15 in the probands of the two families as
determined by SNP array. The 0.88 Mb duplication of family 1 extends from chr11:2,742,159 to chr11:3,632,246 bp. The 1.13 Mb duplication of
family 2 extends from chr11:2,656,311 to chr11:3,782,347 bp (GRCh37/hg19)




Fig. 2 (See legend on next page.)
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876C12, chr11q22.3, red) located outside the duplication
were used for the metaphase FISH (Additional file 4:
Figure S4, top panel). FISH on interphase nuclei was
performed by using the BAC clones RP11-11A9 (green)
and RP11-81 K4 (red), both located within the dupli-
cated region (Additional file 4: Figure S4, bottom panel).
The absence of signals in chromosomes other than
chromosome 11 in metaphase FISH, and the green-red-
red-green sequence of the fluorescence signals, demon-
strated the presence of an in cis duplication with
inverted orientation.
To investigate the effect of the duplication on genomic
imprinting, we analyzed the DNA methylation of ICR1
and ICR2 in the placenta cells of the proband by Pyrose-
quencing (Fig. 2b) and combined bisulfite restriction
assay (COBRA; Additional file 5: Figure S5). With both
methods, the proband showed a methylation profile
comparable to that of three healthy controls in both
ICR1 and ICR2. Normal ICRs methylation was also ob-
served in the blood leukocytes of the parents. To look
for a possible deregulation of the 11p15 imprinted genes,
we analyzed the RNA levels of CDKN1C and PHLDA2
in placenta cells. We found that CDKN1C expression
was increased 10-fold (P < 0.01; Fig. 2c) and PHLDA2
threefold in the proband when compared with three
healthy controls (P < 0.01; Fig. 2c).
Family 2
The male proband was the only child of non-consan-
guineous healthy parents. He was born by GA 37 +
5 weeks. Birth weight was 3350 g (−0.5 SDS), birth length
51 cm (average), and OFC 35 cm (+0.5 SDS). Apgar scores
were 8/1, 8/5, and 8/10. Neonatal plasma glucose was nor-
mal. In the medical record, it is described that there was
slight cranial asymmetry with left side of parietal and
frontal region a little flat. The head was described as slight
narrow, the nasal bridge as slightly wide, and there was
strabismus and retention testis. Further, there were de-
scribed bilateral dysplastic nails on third, fourth, and fifth
toes. He was affected by Steno-Fallot Tetralogy, diagnosed
on day 1 by echocardiography required because of a
systolic murmur. Operation was performed by age
8 month. Neonatal ultrasound scans of cerebrum and
kidneys were both normal. At 1 year old, he showed slight
frontal bossing, slight hypoplasia of maxilla, slightly flaccid
occiput, and bilateral single palmar creases. Neither um-
bilical hernia nor ear lobe creases were observed. At 8 and
20 months of age, the auxological parameters were still
close to the average: 8 month: weight 9.2 kg (+0.5 SDS),
length 71.5 cm (+0.5 SDS) and OFC 44 cm (−0.5 SDS);
20 month: weight 11.3 kg (−0.5 SDS), length 84.5 cm
(−0.5 SDS) and OFC 46.3 cm (−1.5 SDS). The psycho-
motor development was normal.
The mother was 35 years old, with normal phenotype
except for the presence of bilateral ear lobe creases. Her
height was 170 cm and weight was 56.5 kg. She was
born by GA 41 + 5 weeks, with the birth weight 3740 g
(+0.5 SDS), birth length 53 cm (+1 SDS), and OFC
35.5 cm (+1.5 SDS).
Copy number and DNA methylation of the chromo-
some 11p15.5 region were first analyzed by MS-MLPA.
Increased hybridization signal at ICR2 and KCNQ1
exons 13–17 and slight loss of ICR2 methylation were
identified in the proband and his mother, while ICR1,
IGF2, H19, and control probes showed normal copy
number and methylation status (Additional file 6:
Figure S6), indicating the presence of an inherited
partial duplication of the 11p15.5-p15.4 imprinted
gene cluster.
To better define the DNA methylation abnormality
of the 11p15.5-p15.4 region in the proband and his
mother, the methylation levels of the ICRs were de-
termined by pyrosequencing in the trio. As shown in
Fig. 2d, the methylation profiles of both ICRs were
normal in the father, while the proband and his
mother showed normal methylation of ICR1 but hy-
pomethylation of ICR2 at a level comparable with
other previously described ICR2 duplication carriers
(See figure on previous page.)
Fig. 2 Characterization of the duplications. a–c Characterization of the 0.88 Mb duplication in family 1. a Analysis of 11p15 microsatellite markers
showing the segregation of the duplication in three generations. The haplotype of the chromosome carrying the duplication is shadowed. Gray
color of II-2 and III-2 indicates a growth restriction observed only in childhood. b DNA methylation analysis of ICR1 and ICR2 as determined by
Pyrosequencing. Line chart reporting the methylation level (%) of seven CpGs of ICR2 and three CpGs of ICR1.The placenta DNAs of the proband
(III-3) and a healthy control (Plac. N 1) and leukocyte DNAs of the parents (II-1 and II-2) and a healthy control (normal Ctrl 1) showed similar
methylation patterns at both ICRs. Two BWS patients carrying a duplication of the entire domain [17, 18], Dupl Ctrl, have been analyzed as
controls. c Real-time messenger RNA (mRNA) expression analysis of CDKN1C and PHLDA2 normalized to the GAPDH control gene in the placenta
cells of the proband (III-3) and three normal controls (Ctrl 1, 2, 3). Experiments were performed in triplicate and statistical significance determined
by Student’s t test. d–e Characterization of the 1.13 Mb duplication in family 2. d DNA methylation analysis at ICR1 and ICR2 determined by
Pyrosequencing in the trio as described in b. The proband (III-1) and his mother (II-2) show ICR2 methylation level similar to two BWS patients
carrying ICR2 duplications (Dupl Ctrl 1 and 2) and lower than the father (II-1) and two healthy controls. ICR1 methylation of the proband and his
parents is comparable to that of two healthy controls (normal Ctrl 1 and 2). e Analysis of 11p15 microsatellite markers showing a de novo
paternal duplication in the mother and a maternally inherited duplication in the proband. The haplotype of the chromosome carrying the
duplication is shadowed
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[17, 18]. The allele-specific methylation analysis could
not be performed because of the absence of polymor-
phisms in the ICR2 sequence. Nevertheless, the ob-
served hypomethylation suggests that the duplicated
ICR2 fails to acquire or maintain the maternal im-
prints in the proband.
The inheritance of the duplicated region in the pro-
band, his parents and maternal grandparents, was deter-
mined by analyzing the 11p15 microsatellite markers.
The segregation and signal intensity of the D11S4088
marker, located in the duplicated region, confirmed that
the duplication was maternally inherited in the proband
and demonstrated that it originated de novo from the pa-
ternal chromosome in the mother (Fig. 2e and Additional
file 7: Figure S7). The markers, D11S4046, D11S922, and
TH, did not show any allelic imbalance in the proband
and his mother, consistent with their localization outside
of the duplicated region (Additional file 7: Figure S7).
To determine the chromosomal location of the
duplicated region, the cultured blood leukocytes of the
proband were analyzed by FISH. The BAC probes
hybridizing within the duplicated region, RP11-11A9
(chr11: 3236552-3356012, green) and RP11-699D10
(chr11: 2.9–3.04 Mb, red), were used. As in family 1, the
results of the metaphase FISH indicated that the dupli-
cation was in cis (Additional file 8: Figure S8, top panel),
while the FISH on interphase nuclei demonstrated the
inverted orientation of the duplication (Additional file 8:
Figure S8, bottom panel).
Discussion
Maternal duplications of the centromeric domain of the
11p15 imprinted gene cluster generally result in SRS
phenotype. In this study, we describe two familial cases
with overlapping maternal duplications that partially
affect the centromeric domain and show contrasting
growth phenotypes.
Both the rearrangements described in this study
duplicate the CDKN1C gene and two of its putative
enhancers on the maternal chromosome 11p15 [16].
However, only the 0.88 Mb duplication (family 1) is as-
sociated with growth restriction. The most likely explan-
ation of this discrepancy is the presence of KCNQ1OT1
and an unmethylated ICR2 in the 1.13 Mb but not in
the 0.88 Mbp duplication (Fig. 3). Expression of
KCNQ1OT1 resulting from ICR2 hypomethylation likely
leads to down-regulation of the duplicated CDKN1C and
PHLDA2 in the family 2 proband. His normal growth
phenotype suggests that the KCNQ1OT1 transcript is
unable to silence both copies of CDKN1C on the mater-
nal chromosome (Fig. 3). Conversely, the normally
methylated ICR2 in the family 1 proband results in
KCNQ1OT1 repression and over-expression of the du-
plicated CDKN1C and PHLDA2. Similarly, CDKN1C
over-expression probably also occurs in the cases with
larger maternal duplications maintaining ICR2 methyla-
tion [13–15].
Both the probands mothers are carriers of the duplica-
tions but on their paternal chromosomes. The family 1
mother (II-2) was growth restricted during her infancy.
This phenotype likely results from CDKN1C expression
on both maternal and paternal 11p15 chromosomes
(Fig. 3). No CDKN1C deregulation is expected instead in
the mother of family 2 because of the KCNQ1OT1 dupli-
cation and ICR2 hypomethylation.
Maternal duplication of the entire centromeric domain
or the entire 11p15 imprinted gene cluster is generally
associated with clinical features of SRS and quite severe
growth restriction (birth weight and length z scores −
2.5/−7 SDS; postnatal growth restriction −2.5/−6.4 SDS;
[19]). In contrast, the family 1 proband showed limited
growth restriction and no other characteristics of SRS.
Also, the occurrence of a compensatory growth later in
development (he was 14 months old at the last examin-
ation) cannot be excluded. An even milder phenotype
was observed in the second brother (III-2) of the pro-
band, who is also a carrier of the duplication. He was of
short stature in the first 3 years of life (height around
20–25th centile: 41 cm at birth, 65 cm (−1.5 SDS) at
6 months, 89 cm at 29 months (−0.5 SDS)), had
hypoglycemia at birth, and was affected by ADHD. The
attenuated phenotypes may be due to the limited exten-
sion of the 0.88 Mb duplication into the centromeric do-
main leaving out some of the putative CDKN1C
enhancers (Fig. 3). It is worth to mention, however, that
a mild SRS-like phenotype with ADHD was recently re-
ported associated with a 1.9 Mb maternal duplication
encompassing the entire 11p15.5 cluster [19].
Only a few other duplications encompassing partially
the centromeric domain of the 11p15 imprinted gene
cluster have been described so far. Two of these are 50
and 160 kb long, respectively, and both were associated
with BWS upon maternal transmission. The 50-kb dupli-
cation spans from intron 1 to intron 2 of KCNQ1 and was
associated with ICR2 hypomethylation [9]. The 160 kb du-
plication spans from intron 9 to exon 15 of KCNQ1 and
included a non-methylated copy of ICR2 and the 5′ part
of the KCNQ1OT1 gene [17]. In both cases, the BWS
phenotype likely results from the expression of the mater-
nal KCNQ1OT1 allele causing CDKN1C repression in cis.
A complex 277 Kb rearrangement on the paternal
chromosome 11p15 has been recently described associ-
ated with SRS [20]. In this case, a small portion of
KCNQ1OT1 and the entire CDKN1C gene were dupli-
cated, but these duplications were discontinuous and did
not include ICR2. In this case, the SRS phenotype likely
results from the unregulated expression of CDKN1C on
the paternal chromosome.
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The 1.13-Mb duplication described in this study has
some similarities with the 160 kb duplication associated
with BWS [17]. Both rearrangements are present in cis
and in inverted orientation and include a duplicated in-
complete but likely functional copy of KCNQ1OT1 and
a hypomethylated ICR2. However, the former rearrange-
ment is more extended toward the centromere and in-
cludes CDKN1C. The consequence is that the 160 kb
duplication results in reduced CDKN1C expression and
BWS, while the 1.13-Mb duplication is associated with
normal growth and likely normal CDKN1C level (Fig. 3).
The Tetralogy of Fallot (TOF) affecting the proband of
family 2 is a severe congenital heart malformation (MIM
#187500) with both environmental and genetic etiology.
The genetics of TOF is complex and involves many loci,
but studies performed on large cohorts have not identi-
fied any strict association with defects on chromosome
11p [21, 22]. Nevertheless, a few cases of paternal 11p15
Fig. 3 Observations and predictions concerning the two duplications. Diagram summarizing the molecular and clinical phenotypes of the
subjects under study. The duplicated regions are depicted separately from the chromosomes and connected to the breakpoints by blue lines. The
inverted orientation of the duplications is shown. Representative imprinted genes are shown in blue if paternally expressed or in red if maternally
expressed. Light colors are used to indicate repressed genes, full colors for active genes. Arrows indicate the orientation of transcription. Filled
lollipops: methylated ICR2; open lollipops: non-methylated ICR2. Green rectangles: putative CDKN1C enhancers as reported in [16]. Note that in III-1
of family 2 it is likely that only one copy of CDKN1C is silent, but it is not possible to determine which is silent and which is active. Asterisk
represents growth restriction was observed only in childhood
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duplications with BWS and cardiac malformations in-
cluding TOF have been described [23–25]. Therefore,
the involvement of 11p15 genes in the etiology of rare
TOF cases deserves further investigations.
Ear lobe creases are a common sign of BWS [1]. Al-
though more frequently associated with CDKN1C alter-
ations, they can be found in BWS cases with other types
of 11p15.5 molecular defect including paternal duplica-
tions. The finding of such sign in the mother of family 2
proband is intriguing and may be due to altered expres-
sion of some 11p15.5 genes or may be coincidental and
have different causes.
In summary, our study is an example of how the ana-
lysis of the small copy number variation (CNVs) affect-
ing the imprinted gene clusters can increase our
understanding on the imprinting regulatory mechanisms
and help to predict the clinical phenotypes resulting
from such type of rearrangements.
Methods
Biological samples
DNA from peripheral blood leukocytes of all the family
members was extracted by an automated Chemagic
Magnetic Separation Module (PerkinElmer, Waltham,
MA, USA). DNA from buccal swab samples of the rela-
tives of the proband from family 1 was extracted by
using the Maxwell 16 LEV Buccal Swab DNA kit (Pro-
mega, Madison, WI, USA).
Cells from umbilical cord and placenta of the proband
from family 1 and three normal controls were cultured
in BIOAMFTM-3 (BI-USA Inc., Cromwell, CT, USA).
DNA from cell culture of placenta and umbilical cord
and amniotic fluid cells was extracted directly using the
Maxwell 16 LEV Blood DNA kit (Promega, Madison,
WI, USA). RNA was extracted by using TRIzol reagent
(Life technologies, Darmstadt, Germany), according to
the protocol of the manufacturer.
All the genetic analyses were performed after informed
consent had been obtained. All the clinical and research
have been done following the ethical rules of the Danish
and Italian law.
Growth parameters
Z scores of each member under study were calculated
referring to standard growth rate of Denmark.
Copy number variation detection
MS-MLPA. MS-MLPA was performed on genomic DNA
of the proband from family 2, his parents and maternal
grandparents. The SALSA MS-MLPA kit ME030-C3 for
BWS–SRS (MRC-Holland, Amsterdam, the Netherlands)
was used following the manufacturer’s instructions. The
amplified products were separated by capillary electro-
phoresis using ABI 3130 Genetic Analyzer (Applied
Biosystems, CA, USA). Data was analyzed using the
built-in MS-MLPA tool of the software Genemarker v
2.2.0 (Softgenetics, USA).
CGH array
The samples were analyzed using the SurePrint G3 Hu-
man CGH microarray 180k (Agilent Technologies Inc.,
Santa Clara, CA, USA). Sample and reference genomic
DNA (500 ng) were labelled with Cy5 (reference) or Cy3
(specimen) using the Sure Tag Complete DNA labelling
Kit (Agilent Technologies Inc.) and purified as described
in the manufacturer’s protocol. Labelled sample and ref-
erence DNA were pooled, and 5-μl human COT-1 DNA
(1 mg/ml), 10× blocking agent, and 2× hybridization
buffer were added. Hybridization was performed for
24 h at 65 °C. Scanning and image acquisition were car-
ried out using an Agilent microarray scanner and micro-
array image files were analyzed using CytoGenomics,
version 2.9 (Agilent Technologies Inc.). Copy number
was determined using the adm-2 algorithm and profile
deviations consisting of four or more neighboring oligo-
nucleotides were considered genomic aberrations. The
resolution is thus approximately 50 kb.
Detected copy number gains or losses were compared
with our in-house database of CNVs and with public




Whole-genome copy number variation (CNV) analysis
was carried out using the CytoScan HD array platform
(Affymetrix, Santa Clara, CA). This array contains more
than 2.6 million markers for copy number analysis and
approximately 750,000 SNPs that fully genotype with
greater than 99 percent accuracy. The CytoScan HD
assay was performed starting with 250 ng DNA as previ-
ously described [26]. Both quality control step and copy
number analysis were performed using the Chromosome
Analysis Suite Software version 2.0. The raw data file
(.CEL) was normalized using the default options; an un-
paired analysis was performed using as baseline 270
HapMap samples in order to obtain copy numbers value
from .CEL files; while the amplified and/or deleted re-
gions were detected using a standard Hidden Markov
Model (HMM) method. Karyotype was designated
according to ISCN 2013, and base pair position was
derived from the University of California Santa Cruz
(UCSC) Genome Browser (http://genome.ucsc.edu/cgi-bin/
hgGateway), build GRCh37 (hg19).
Microsatellite analysis
D11S4088 short tandem repeat (STR) marker mapping
to the duplicated region and TH, D11S4046 and
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D11S900 STR mapping at the 11p15.5-4 region outside
the duplication, were analyzed in the probands and their
relatives to verify the origin of duplication and follow
the segregation through the three generations. Primers
specific for the STR were obtained from NCBI Genome
Database together with the PCR conditions. PCR ampli-
fication of 100-ng DNA was done using forward primer
end labelled with Fam or Hex. Twenty-eight cycles of
PCR products were run on the fluorescent capillary
system ABI 3130XL. Data were analyzed using Gene-
Mapper Software.
Microsatellites of chromosome 7 (D7S657, D7S502,
D7S686, D7S1830) were also analyzed to exclude the
UPD7 associated with the 10 % of the SRS cases (data
not shown).
Fluorescence in situ hybridization
FISH analysis was performed on metaphase or interphase
nuclei spread from PHA-stimulated umbilical cord cell
culture (proband, family 1) and peripheral blood leuko-
cytes (proband, family 2) using standard procedures. The
RP11-699D10 (red) and RP11-11A9 (green) BlueFISH
probes (Illumina) targeting the 11p15.4 duplicated region
were used for FISH analyses of proband of family 1. RP11-
179B7 (red) on 11q22.3 served as control for chromosome
11 to exclude a translocation defect. RP11-11A9 (green)
and the BAC clone RP11-81 K4 DNA labelled with red
fluorophore using a non-enzymatic nucleic acid labelling
method (ULSTM, Kreatech Diagnostics Amsterdam, The
Netherlands) were used as probes for the interphase FISH
on proband of family 2. The probes used for the meta-
phase FISH were RP11-81K4 (11p15.5-15.4, green) and
RP11-876C12 (11q22.3, red). The chromosomes and nu-
clei were counterstained with DAPI. Hybridizations were
analyzed using a Leica DMRB microscope (Leica Micro-
systems A/S, Wetzlar, Germany) or a Nikon Eclipse-1000
epifluorescence microscope (Nikon Instruments, Tokyo,
Japan). Images captured and elaborated using the ISIS
software v. 5.1 (MetaSystems GmbH, Altlussheim,
Germany) or the Genikon systemv. 3.8.5 (Nikon Instru-
ments, Tokyo, Japan).
DNA methylation analysis
Two micrograms of genomic DNA extracted from cells/
tissues was treated with sodium bisulfite by using the
EpiTect Bisulfite kit (Qiagen-Italia, Milan, Italy) follow-
ing the manufacturer’s protocol. The converted DNA
was analyzed by COBRA and Pyrosequencing.
COBRA
Bisulfite-treated DNA was amplified with primers spe-
cific for CTCF target site 1 of ICR1 and ICR2. The PCR
products were then digested with BstUI (CGCG) and the
digestion products were run on a polyacrylamide gel to
separate the digested (methylated) from the undigested
(non-methylated) bands. The percentage of methylation
was calculated by computer quantitation of the gel fol-
lowing exposure to phosphorimager. Primers sequences,
PCR, and restriction enzyme reaction conditions were
previously described [27, 28].
Pyrosequencing
In order to obtain more quantitative DNA methylation
data, pyrosequencing was performed to assess methyla-
tion at seven CpGs within ICR2 and three CpGs within
ICR1, as control. Primers and PCR conditions were pre-
viously described [29] (KvDMR1-F 5′-TTAGTTTTTTG
YGTGATGTGTTTATTA-3′ and KvDMR1-R 5′-Biotin/
CCCACAAACCTCCACACC-3′; for sequencing: Kv
DMR1-S 5′-TTGGTAGGTATAGAAATTGGGG-3′) and
[30] (H19DMR-CTCF3 F 5′-TTGGTAGGTATAGAA
ATTGGGG-3′ and H19DMR-CTCF3R 5′-Biotin/ACA
CYTAACTTAAATAAC-3′; for sequencing: H19DMR-
CTCF3 S2 5′-GTGGATTTAAAAGTGGT-3′). Sequen-
cing of 10 μl of PCR product was carried out on a PSQ
96MD system with the PyroGold SQA Reagent Kit
(Qiagen-Italia, Milan, Italy), and results were analyzed
using the Q-CpG software (V.1.0.9Pyrosequencing).
Gene expression analysis
About 1 μg of total RNA extracted from placenta and
umbilical cord cultured cells was treated with RNase-
free DNase, and first-strand complementary DNA
(cDNA) was synthesized using Quantitech Reverse Tran-
scription Kit (Qiagen-Italia, Milan, Italy), according to
the protocol of the manufacturer. CDKN1C expression
was examined by SYBR Green quantitative real-time
PCR (Power SYBR Green Master Mix Applied Biosys-
tems, Foster City, CA, USA). Reactions were run on ABI
PRISM 7500 using the default cycling conditions. Rela-
tive expression was determined using the ΔΔCT method,
and gene expression values were normalized to the ex-
pression of the GAPDH reference gene. The primers
used are CDKN1C For 5′- AGAGATCAGCGCCT
GAGAAG-3′ and CDKN1C Rev 5′-CACCTTGGGAC
CAGTGTACC-3′ [17]; GAPDH For 5′-CACCATCTTC
CAGGAGCGAG-3′ and GAPDH Rev 5′-TCACGCCA
CAGTTTCCCGGA-3′.
Additional files
Additional file 1: Figure S1. Comparative genomic hybridization
analysis performed on DNA of the proband from family 1. The extension,
the genomic localization (GRC h37/hg19) and the genes included in the
duplication are shown. (PDF 54 kb)
Additional file 2: Figure S2. Single nucleotide polymorphism analysis
of genomic DNA from relatives of family 1. I-1 = maternal grandfather,
II-2 = mother, III-1 = first brother of the proband, and III-2 = second
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brother of the proband. Note that the duplication is present in II-2 and
III-2 but not in I-1 and III1. (PDF 127 kb)
Additional file 3: Figure S3. Segregation of the haplotype associated
with the duplication in family 1. Note that the haplotype associated
with the duplication segregates from I-1 to II-2, III-2, and III-3 and that
only the D11S4088 marker shows allelic imbalances in II-2, III-2, and III-3.
(PDF 208 kb)
Additional file 4: Figure S4. FISH analysis on metaphase nuclei (top
panel) of cultured cells derived from the umbilical cord of the proband of
family 1 by using BAC probes for 11p15.5-15.4 (RP11-81K4, 2798699-2970438,
green) and 11q22.3 (RP11-876C12, 103,804,669-103,982,517, red). The green
signal on both homologues is visible only at chr11p, demonstrating the
presence of an in cis duplication and excluding an unbalanced translocation.
FISH analysis on interphase nuclei (bottom panel) using the BACs RP11-11A9
(3,236,552-3,356,012, green) and RP11-81K4 (red), hybridizing within the
duplication. Note that single and duplicated signals can be seen on the two
homologues, respectively. The green-red-red-green order of the duplicated
signals indicates that the duplication is inverted. (PDF 51 kb)
Additional file 5: Figure S5. DNA methylation analysis of ICR1 and
ICR2 in family 1, determined by combined bisulphite restriction assay
(COBRA). The placenta DNAs of the proband and three healthy controls, the
peripheral blood DNAs of the proband parents, one control, and two BWS
patients (Dupl Ctrl) carrying a duplicated unmethylated ICR2 [15, 16]. Note that
the proband (III-3) and his parents show normal methylation at both ICR1 and
ICR2. Unme= non-methylated band, me =methylated band. (PDF 66 kb)
Additional file 6: Figure S6. DNA methylation (top) and copy number
(CN, bottom) analyses at 11p15 region in family 2, determined by MS-
MLPA. The histograms represent the normalized DNA methylation of ICR1
and ICR2 and CN of the genomic region spanning from the NSD1 to
KCNQ1 gene. The CN range that is considered normal is shadowed. Note
that methylation of ICR2 is abnormally low while CN values of ICR2 and
KCNQ1 exon 13-17 are abnormally high in the proband and his mother.
(PDF 130 kb)
Additional file 7: Figure S7. Note that the haplotype associated with
the duplication segregates from I-1 to II-2 and III-1 and that only the
D11S4088 marker shows allelic imbalances in II-2 and III-1. (PDF 141 kb)
Additional file 8: Figure S8. FISH analysis on metaphase nuclei (top
panel) of cultured cells derived from peripheral blood leukocytes of the
proband of family 2 by using BAC probes for 11p15.5-15.4 (RP11-11A9,
3,236,552-3,356,012, green) and 11q22.3 (RP11-179B7, 104,298,339-104,
459,797, red). The green signal on both homologues is visible only at
chr11p, demonstrating the presence of an in cis duplication and excluding
an unbalanced translocation. FISH analysis on interphase nuclei (bottom
panel) using the BACs RP11-699D10 (2.9–3.0 Mb, red) and RP11-11A9
(green), hybridizing within the duplication. Note that single and duplicated
signals can be seen on the two homologues, respectively. The red-green-
green-red order of the duplicated signals indicates that the duplication is
inverted. (PDF 52 kb)
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